Reblozyl 75 MG vials
Ended Awarded
- Contract number
- SPE2DR26FN2BA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,658
Award facts
- Contract value 100% obligated
- $34,658.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $34,658.44 delivery order to AmerisourceBergen Drug Corp on June 3, 2026, for Reblozyl 75 mg vials, with a ceiling value of $34,658.44 and ultimate completion date of June 25, 2026.
Place of performance is Conshohocken, PA. The order is priced firm fixed-price and carries no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FN2BA?
SPE2DR26FN2BA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2026.
How much is contract SPE2DR26FN2BA worth?
The government has obligated $34,658 on SPE2DR26FN2BA.
Is contract SPE2DR26FN2BA an order under another contract?
Yes. SPE2DR26FN2BA is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FN2BA competed?
The extent of competition for SPE2DR26FN2BA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award